Australian Infrastructure Stock News

ASX:BOT
ASX:BOTPharmaceuticals

Will Botanix Pharmaceuticals’ (ASX:BOT) Investor Outreach Reinforce Management Credibility or Raise Fresh Questions?

Botanix Pharmaceuticals recently held a special call to update investors on its quarterly activity report and Sofdra® topical gel launch, and is set to present at the 2025 Canaccord Genuity Drug & Device Conference with CEO Howie McKibbon as speaker. These events highlight the company's efforts to communicate operational progress and product momentum to the market at key industry forums. We’ll explore how management’s proactive communication on the Sofdra launch is shaping Botanix...
ASX:NXL
ASX:NXLSoftware

Nuix (ASX:NXL) Valuation in Focus Following CEO Transition and Strategic Leadership Changes

Nuix (ASX:NXL) is drawing attention after CEO Jonathan Rubinsztein announced plans to step down at the end of October, with John Ruthven stepping in as interim CEO. Leadership transitions such as this can prompt fresh scrutiny from investors who are curious about the company’s next strategic moves. See our latest analysis for Nuix. Nuix shares have been on a turbulent ride lately, with the latest leadership change drawing even more focus. Despite a brief uptick, the 1-day share price return...